Sumitomo Chemical India (SUMICHEM) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
28 Oct, 2026Executive summary
Q2FY27 revenue was ₹907.309 crore, down 2% YoY, as lower volumes and high-cost inventory pressured margins; H1 revenue was ₹1,970.655 crore, down 1%, while reported net profit rose 5% to ₹371.918 crore.
Domestic sales held up better than exports amid deficient rainfall, delayed sowing and weaker agrochemical demand; H2 demand remains uncertain.
Financial highlights
Q2 gross profit was ₹369.1 crore, down 8% YoY; operating EBITDA fell 15% to ₹185.8 crore and net profit fell 11% to ₹157.404 crore.
H1 gross profit declined 2% to ₹785.8 crore and operating EBITDA fell 4% to ₹419.1 crore; reported net profit rose 5% to ₹371.918 crore.
Consolidated Q2 PBT before exceptional items was ₹210.167 crore versus ₹237.847 crore YoY; H1 PBT was ₹498.4 crore, up 4%.
Consolidated H1 basic and diluted EPS was ₹7.45 versus ₹7.13; Q2 EPS was ₹3.14 versus ₹3.56 YoY.
Outlook and guidance
H2FY27 is expected to remain challenging amid low reservoir levels, El Niño risk and possible constraints on crop acreage; margins are expected to remain within historical ranges.
Priorities include directing resources to stronger-demand regions, pushing differentiated and key driver products, dynamic pricing, protecting margins and reducing inventory.
Capital projects are progressing to previously communicated timelines; no specific export growth forecast was offered.
Latest events from Sumitomo Chemical India
- Revenue and profit fell amid industry headwinds, but strategic investments and new launches support future growth.SUMICHEM
Q4 23/24 - Q1FY27 profit and margins rose, driven by exports and an insurance claim despite sector headwinds.SUMICHEM
Q1 26/27 - Record profit, margin expansion, and a ₹1.30 dividend in FY26 amid regulatory risks.SUMICHEM
Q4 25/26 - 9MFY26 revenue rose 5% with margin gains, but Q3 saw profit drop from one-time Labour Code charge.SUMICHEM
Q3 25/26 - H1 FY26 delivered 9% revenue growth, robust cash flow, and new launches despite Q2 headwinds.SUMICHEM
Q2 25/26 - Q1FY25 saw strong revenue and profit growth, improved margins, and ongoing legal and seasonal risks.SUMICHEM
Q1 24/25 - Record H1 FY25 profit and margin growth driven by new products, exports, and strong demand outlook.SUMICHEM
Q2 24/25 - Double-digit growth, record margins, and strong outlook, amid regulatory and climate risks.SUMICHEM
Q4 24/25 - Record Q1FY26 revenue and profit growth, with strong margins and ongoing regulatory risks.SUMICHEM
Q1 25/26